Frequently Asked Questions
The market is segmented based on , Disease Type (Relapsing–Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing–Remitting Multiple Sclerosis (RES)), Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies), Drug Type (Branded, Generic), End User (Hospital and Clinics, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2030.
.
The North America Multiple Sclerosis Treatment Market size was valued at USD 2879.60 USD million in 2022.
The North America Multiple Sclerosis Treatment Market is projected to grow at a CAGR of 9% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America.
